-
Update on ECMO for COVID-19 Patients. Weaning – V-A ECMO with Cardiogenic Shock. Recombinant Activating Factor VII
Update on ECMO for COVID-19 Patients. Weaning – V-A ECMO with Cardiogenic Shock. Recombinant Activating Factor VII
This Perfusion Meeting was approved for 3.6 Category 1 CEU by ABCP Vanderbilt University Medical Center; Department of CV Surgery: Faculty Forum Update on ECMO for COVID-19: What have we learned? Faculty: J. Hoffman, MD, Matt Warhoover, CCP, A. Lepore, CCP Tammy Sparacino Journal Club: Early experience of pump-controlled retrograde trial off for weaning...
$54